Mineral and Organic Matrix Composition at Bone Forming Surfaces in Postmenopausal Women with Osteoporosis Treated With Either Teriparatide or Zoledronic Acid.
The ability of bone to resist fracture is dependent on the composite nature of its mineral and organic matrix content. Teriparatide (TPTD) and zoledronic acid (ZOL) are approved anabolic and antiresorptive therapies,...